Condition
    Moderate Evidence
    Effectiveness 2/5

    Magnesium for Myasthenia Gravis

    Magnesium is a caution item in myasthenia gravis, not a treatment — it physiologically reduces acetylcholine release at the neuromuscular junction, the exact signal already failing in MG, and intravenous magnesium has triggered myasthenic crises.

    Overview

    Magnesium is a caution item in myasthenia gravis, not a treatment — it physiologically reduces acetylcholine release at the neuromuscular junction, the exact signal already failing in MG, and intravenous magnesium has triggered myasthenic crises.

    Verdict

    Insufficient evidence

    How It Works

    Magnesium competes with calcium at the presynaptic nerve terminal, reducing acetylcholine release into the neuromuscular junction. In MG, where acetylcholine receptors are already blocked by antibodies, this additional brake can measurably worsen weakness.

    Dosing & Protocol

    Typical dose

    Recommended dose
    Avoid supplementation unless a neurologist confirms need
    Expected timeframe
    N/A

    Protocol

    form
    Not applicable
    duration
    Not applicable
    co factor
    Evidence is insufficient and the direction of risk is negative: magnesium reduces presynaptic acetylcholine release at the neuromuscular junction, and parenteral magnesium has precipitated myasthenic crisis in case reports. No trial supports supplementation in myasthenia gravis. Do not start magnesium without neurologist approval.
    titration
    Not applicable
    starting dose
    Not applicable

    Evidence

    What the studies say

    Case reports and physiological studies document MG worsening with intravenous magnesium (used for pre-eclampsia and severe asthma), and neurologists routinely advise MG patients to avoid high-dose magnesium. Risk from dietary magnesium is negligible; the concern is concentrated supplements, magnesium-containing antacids, and laxatives. There is no evidence of benefit for MG — only risk documentation.

    Myasthenia Gravis: A Rare Neurologic Complication of Immune Checkpoint Inhibitor Therapy

    Score: 3/10
    2022
    case_study
    n=1

    Shames A, et al

    Many medications, including fluroquinolone, aminoglycoside, magnesium sulfate, quinidine, and select beta blockers, are known to unmask or exacerbate symptoms of myasthenia gravis.

    View source

    Safety

    Caveats

    High-dose oral magnesium, IV magnesium, and magnesium-containing antacids/laxatives can worsen MG weakness. If supplementation is genuinely needed (e.g. documented deficiency), it should be neurologist-supervised.

    Less likely to help if

    Everyone with myasthenia gravis - the concern here is harm, not lack of benefit.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.